The application relates to the technical field of
rhodamine derivatives, and specifically discloses a
selenium-containing
rhodamine derivative and application thereof. The application innovatively proposes a
selenium-heavy-atom-containing
rhodamine derivative, which has a visible light absorption
wavelength close to the near-
infrared region of 700 NM, which enables it to penetrate deeper tissue sites for deep treatment; meanwhile, the
selenium-heavy-atom-containing
rhodamine derivative also exhibits a high
triplet state conversion rate, and can efficiently generate
reactive oxygen species under
light excitation conditions, thereby strengthening the killing effect on
cancer cells and
cancer tissues. Compared with the prior art, the selenium-heavy-atom-containing
rhodamine derivative of the application can realize efficient removal of
cancer cells and cancer tissues at a concentration of only nanomolar order, thereby significantly improving the treatment efficiency and reducing the
drug dosage; meanwhile, the preparation process of the
rhodamine derivative provided by the application is simple and easy to implement, and a relatively high synthesis yield can be obtained, and the rhodamine derivative is more suitable for large-scale, low-cost production and application.